Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT01308580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m² and at 25 mg/m² Every 3 Weeks in Combination With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen
Study identification
- NCT ID
- NCT01308580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 1,200 participants
Conditions and interventions
Conditions
Interventions
- Cabazitaxel (XRP6258) Drug
- Prednisone (or Prednisolone) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2011
- Primary completion
- Jul 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- Apr 16, 2017
2011 – 2015
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840002 | Muscle Shoals | Alabama | 35661 | — |
| Investigational Site Number 840004 | Hot Springs | Arkansas | 71913 | — |
| Investigational Site Number 840008 | Anaheim | California | 92801 | — |
| Investigational Site Number 840010 | La Jolla | California | 92093 | — |
| Investigational Site Number 840001 | San Bernardino | California | 92404 | — |
| Investigational Site Number 840021 | Stamford | Connecticut | 06902 | — |
| Investigational Site Number 840023 | Jacksonville | Florida | 32256 | — |
| Investigational Site Number 840013 | Lakeland | Florida | 33805 | — |
| Investigational Site Number 840003 | Port Saint Lucie | Florida | 34952 | — |
| Investigational Site Number 840007 | New Orleans | Louisiana | 70112 | — |
| Investigational Site Number 840014 | Baltimore | Maryland | 21231 | — |
| Investigational Site Number 840005 | Rockville | Maryland | 20850 | — |
| Investigational Site Number 840017 | Saint Louis Park | Minnesota | 55416 | — |
| Investigational Site Number 840011 | Jackson | Mississippi | 39202 | — |
| Investigational Site Number 840016 | Lincoln | Nebraska | 68506 | — |
| Investigational Site Number 840015 | East Orange | New Jersey | 07018 | — |
| Investigational Site Number 840024 | Raleigh | North Carolina | 27607 | — |
| Investigational Site Number 840020 | Akron | Ohio | 44302 | — |
| Investigational Site Number 840006 | Pawtucket | Rhode Island | 02860 | — |
| Investigational Site Number 840025 | Chattanooga | Tennessee | 37421 | — |
| Investigational Site Number 840012 | Corpus Christi | Texas | 78405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 151 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01308580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01308580 live on ClinicalTrials.gov.